Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Biography
Dr. Vasu Divi is a distinguished expert in the field of head and neck cancer treatment, renowned for his dual roles as a cancer surgeon and reconstructive surgeon. With a specialized focus on high-risk and advanced skin cancers, oral cavity cancers, and osteoradionecrosis of the head and neck, Dr. Divi stands at the forefront of medical innovation. As a national authority in cutaneous squamous cell carcinoma of the head and neck, Dr. Divi spearheads Stanford's clinical trial program dedicated to this condition. His trial portfolio encompasses both neoadjuvant and adjuvant applications of immunotherapy, reflecting his commitment to advancing treatment methodologies. Actively engaged in research, Dr. Divi endeavors to define the optimal treatment approach for this disease, integrating immunotherapy to enhance patient outcomes.
View Full Biography »
Professional Summary
Education & Certifications
- Fellowship: Massachusetts Eye and Ear Infirmary Dept of Otolaryngology (2010) MA
- Internship: University of Michigan (2005) MI
- M.S., Stanford University, Masters in Clinical Informatics Management (MCiM) (2022)
- Board Certification: American Board of Otolaryngology, Otolaryngology (2010)
- Fellowship, Harvard Medical School / Mass Eye and Ear Infirmary, Head & Neck Surgical Oncology, Microvascular Reconstruction, Skull Base Surgery (2010)
- Residency, University of Michigan, Otolaryngology - Head and Neck Surgery (2009)
- M.D., University of Michigan, Medical School (2004)
- B.A., University of Michigan, Economics (1998)
Administrative Appointments
- Chair, Quality, Patient Safety, and Effectiveness Committee, Stanford Health Care (2021 - 2023)
- Director of Stanford Head and Neck Surgery Fellowship, American Head and Neck Society (2013 - Present)
- Medical Director of Quality, Stanford Cancer Center (2021 - 2023)
Publications
-
Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma
Warner, K. A., Adams, A., Bernardi, L., Nor, C., Finkel, K. A., Zhang, Z., … Noer, J. E. (2013). Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma. ORAL ONCOLOGY, 49(11), 1059–66. -
CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
Murillo-Sauca, O., Chung, M. K., Shin, J. H., Karamboulas, C., Kwok, S., Jung, Y. H., … Sunwoo, J. B. (2014). CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma. Oncotarget, 5(16), 6854–66. -
Anterolateral approach to the upper cervical spine: Case report and operative technique
Song, Y., Tharin, S., Divi, V., Prolo, L. M., & Sirjani, D. B. (2015). Anterolateral approach to the upper cervical spine: Case report and operative technique. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 37(9), E115–E119. -
A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers.
Pollom, E. L., Wang, E., Bui, T. T., Ognibene, G., von Eyben, R., Divi, V., … Hara, W. Y. (2015). A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers. Oral Oncology, 51(12), 1132–37. -
CHEMOTHERAPY ALONE FOR ORGAN PRESERVATION IN ADVANCED LARYNGEAL CANCER
Divi, V., Worden, F. P., Prince, M. E., Eisbruch, A., Lee, J. S., Bradford, C. R., … Wolf, G. T. (2010). CHEMOTHERAPY ALONE FOR ORGAN PRESERVATION IN ADVANCED LARYNGEAL CANCER. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 32(8), 1040–55. -
Metastatic Potential of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
Davis, S. J., Divi, V., Owen, J. H., Bradford, C. R., Carey, T. E., Papagerakis, S., & Prince, M. E. P. (2010). Metastatic Potential of Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 136(12), 1260–66. -
Primary TEP Placement in Patients with Laryngopharyngeal Free Tissue Reconstruction and Salivary Bypass Tube Placement
Divi, V., Lin, D. T., Emerick, K., Rocco, J., & Deschler, D. G. (2011). Primary TEP Placement in Patients with Laryngopharyngeal Free Tissue Reconstruction and Salivary Bypass Tube Placement. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 144(3), 474–476. -
Re-animation and rehabilitation of the paralyzed face in head and neck cancer patients
Divi, V., & Deschler, D. G. (2012). Re-animation and rehabilitation of the paralyzed face in head and neck cancer patients. CLINICAL ANATOMY, 25(1), 99–107. -
Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy?
Spector, M. E., Chinn, S. B., Rosko, A. J., Worden, F. P., Ward, P. D., Divi, V., … Bradford, C. R. (2012). Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy? LARYNGOSCOPE, 122(7), 1507–11. -
Transoral robotic biopsy of the tongue base: A novel paradigm in the evaluation of unknown primary tumors of the head and neck
Abuzeid, W. M., Bradford, C. R., & Divi, V. (2013). Transoral robotic biopsy of the tongue base: A novel paradigm in the evaluation of unknown primary tumors of the head and neck. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 35(4), E126–E130. -
EVALUATION OF CD44 VARIANT EXPRESSION IN ORAL, HEAD AND NECK SQUAMOUS CELL CARCINOMAS USING A TRIPLE APPROACH AND ITS CLINICAL SIGNIFICANCE
Athanassiou-Papaefthymiou, M., Shkeir, O., Kim, D., Divi, V., MATOSSIAN, M., Owen, J. H., … Papagerakis, S. (2014). EVALUATION OF CD44 VARIANT EXPRESSION IN ORAL, HEAD AND NECK SQUAMOUS CELL CARCINOMAS USING A TRIPLE APPROACH AND ITS CLINICAL SIGNIFICANCE. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 27(3), 337–349. -
Use-of cross-sectional imaging in predicting surgical location of parotid neoplasms
Divi, V., Fatt, M. A., Teknos, T. N., & Mukherji, S. K. (2005). Use-of cross-sectional imaging in predicting surgical location of parotid neoplasms. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 29(3), 315–19. -
Use of Pedicled Nasoseptal Flap for Pathologic Oroantral Fistula Closure
Noel, J. E., Teo, N. W., Divi, V., & Nayak, J. V. (2016). Use of Pedicled Nasoseptal Flap for Pathologic Oroantral Fistula Closure. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 74(4). -
Use of Pedicled Nasoseptal Flap for Pathologic Oroantral Fistula Closure.
Noel, J. E., Teo, N. W., Divi, V., & Nayak, J. V. (2016). Use of Pedicled Nasoseptal Flap for Pathologic Oroantral Fistula Closure. Journal of Oral and Maxillofacial Surgery , 74(4), 704 e1–6. -
Consultation via telemedicine and access to operative care for patients with head and neck cancer in a Veterans Health Administration population
Beswick, D. M., Vashi, A., Song, Y., Pham, R., Holsinger, F. C., Rayl, J. D., … Sirjani, D. B. (2016). Consultation via telemedicine and access to operative care for patients with head and neck cancer in a Veterans Health Administration population. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38(6), 925–29. -
Contemporary mandibular reconstruction.
Divi, V., Schoppy, D. W., Williams, R. A., & Sirjani, D. B. (2016). Contemporary mandibular reconstruction. Current Opinion in Otolaryngology & Head and Neck Surgery, 24(5), 433–39. -
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).
Divi, V., Harris, J., Harari, P. M., Cooper, J. S., McHugh, J., Bell, D., … Holsinger, F. C. (2016). Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer. -
Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas
Roberts, T. J., Colevas, A. D., Hara, W., Holsinger, F. C., Oakley-Girvan, I., & Divi, V. (2016). Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas. CANCER, 122(9), 1388–97. -
Third party assessment of resection margin status in head and neck cancer.
Ransohoff, A., Wood, D., Solomon Henry, A., Divi, V., & Colevas, A. (2016). Third party assessment of resection margin status in head and neck cancer. Oral Oncology, 57, 27–31. -
Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics
Divi, V., Ma, Y., & Rhoads, K. F. (2016). Regional variation in head and neck cancer mortality: Role of patient and hospital characteristics. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38, E1896–E1902. -
Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer
Divi, V., Tao, L., Whittemore, A., & Oakley-Girvan, I. (2016). Geographic variation in Medicare treatment costs and outcomes for advanced head and neck cancer. ORAL ONCOLOGY, 61, 83–88. -
Third party assessment of resection margin status in head and neck cancer
Ransohoff, A., Wood, D., Henry, A. S., Divi, V., & Colevas, A. (2016). Third party assessment of resection margin status in head and neck cancer. ORAL ONCOLOGY, 57, 27–31. -
Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
Amoils, M., Lee, C. S., Sunwoo, J., Aasi, S. Z., Hara, W., Kim, J., … Divi, V. (2017). Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes. Head & Neck. -
Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
Chen, M. M., Harris, J. P., Hara, W., Sirjani, D., & Divi, V. (2016). Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 142(12), 1224–30. -
Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer
Divi, V., Chen, M. M., Nussenbaum, B., Rhoads, K. F., Sirjani, D. B., Holsinger, F. C., … Hara, W. (2016). Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer. JOURNAL OF CLINICAL ONCOLOGY, 34(32), 3892-? -
Quality Measures in Breast Reconstruction: A Systematic Review.
Nazerali, R. N., Finnegan, M. A., Divi, V., Lee, G. K., & Kamal, R. N. (2017). Quality Measures in Breast Reconstruction: A Systematic Review. Annals of Plastic Surgery. -
American Joint Committee on Cancer Eighth Edition Changes in Staging Criteria: Implications for Data Collection.
Saraswathula, A., Chen, M., Negoita, S., & Divi, V. (2017). American Joint Committee on Cancer Eighth Edition Changes in Staging Criteria: Implications for Data Collection. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599817721690. -
Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682. -
Jaw Opening Decreases Window to the Deep Parotid Lobe.
Lee, Y.-J., Megwalu, U., Melara, E., Divi, V., Fernandes, V. T., & Sirjani, D. (2018). Jaw Opening Decreases Window to the Deep Parotid Lobe. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599818766317. -
Surrogate for oropharyngeal cancer HPV status in cancer database studies
Megwalu, U. C., Chen, M. M., Ma, Y., & Divi, V. (2017). Surrogate for oropharyngeal cancer HPV status in cancer database studies. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 39(12), 2494–2500. -
Retrograde Parotidectomy and facial nerve outcomes: A case series of 44 patients
Kligerman, M. P., Song, Y., Schoppy, D., Divi, V., Megwalu, U. C., Haughey, B. H., & Sirjani, D. (2017). Retrograde Parotidectomy and facial nerve outcomes: A case series of 44 patients. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 38(5), 533–36. -
Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients.
Saraswathula, A., Chen, M. M., Mudumbai, S. C., Whittemore, A. S., & Divi, V. (2018). Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599818778276. -
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers
Gao, R. W., Teraphongphom, N., de Boer, E., van den Berg, N. S., Divi, V., Kaplan, M. J., … Rosenthal, E. L. (2018). Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers. THERANOSTICS, 8(9), 2488–95. -
Reducing the Time from Surgery to Adjuvant Radiation Therapy: An Institutional Quality Improvement Project.
Divi, V., Chen, M. M., Hara, W., Shah, D., Narvasa, K., Segura Smith, A., … Porter, J. (2018). Reducing the Time from Surgery to Adjuvant Radiation Therapy: An Institutional Quality Improvement Project. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599818768254. -
Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.
Chen, M. M., Harris, J. P., Orosco, R. K., Sirjani, D., Hara, W., & Divi, V. (2018). Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 158(6), 1051–56. -
Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer
Harris, J. P., Chen, M. M., Orosco, R. K., Sirjani, D., Divi, V., & Hara, W. (2018). Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 144(4), 349–59. -
Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure-Reply.
Schoppy, D. W., & Divi, V. (2018). Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure-Reply. JAMA Otolaryngology-- Head & Neck Surgery. -
Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data Negative Margin Rates and Neck Dissection Yield
Schoppy, D. W., Rhoads, K. F., Ma, Y., Chen, M. M., Nussenbaum, B., Orosco, R. K., … Divi, V. (2017). Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data Negative Margin Rates and Neck Dissection Yield. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY. AMER MEDICAL ASSOC. -
Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
Gao, R. W., Teraphongphom, N. T., van den Berg, N. S., Martin, B. A., Oberhelman, N. J., Divi, V., … Rosenthal, E. L. (2018). Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence. Cancer Research. -
Predictors of readmissions after head and neck cancer surgery: A national perspective
Chen, M. M., Orosco, R. K., Harris, J. P., Porter, J. B., Rosenthal, E. L., Hara, W., & Divi, V. (2017). Predictors of readmissions after head and neck cancer surgery: A national perspective. ORAL ONCOLOGY, 71, 106–12. -
Outcomes in Head and Neck Resections That Require Multiple-Flap Reconstructions: A Systematic Review.
Gao, R. W., Nuyen, B. A., Divi, V., Sirjani, D., & Rosenthal, E. L. (2018). Outcomes in Head and Neck Resections That Require Multiple-Flap Reconstructions: A Systematic Review. JAMA Otolaryngology-- Head & Neck Surgery. -
PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma.
Amoils, M., Kim, J., Lee, C., Sunwoo, J. B., Colevas, A. D., Aasi, S. Z., … Divi, A. V. (2018). PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599818788057. -
Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p
Barnes, J., Divi, V., Begaye, A., Wong, R., Coutre, S., Owens, D. K., & Goldhaber-Fiebert, J. D. (2018). Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p. BLOOD ADVANCES, 2(15), 1946–56. -
Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age
Chen, M. M., Colevas, A. D., Megwalu, U., & Divi, V. (2018). Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age. ORAL ONCOLOGY, 84, 71–75. -
Regionalization of Head and Neck Cancer Surgery May Fragment Care and Impact Overall Survival.
Chen, M. M., Megwalu, U. C., Liew, J., Sirjani, D., Rosenthal, E. L., & Divi, V. (2018). Regionalization of Head and Neck Cancer Surgery May Fragment Care and Impact Overall Survival. The Laryngoscope. -
Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis.
Chen, J. J., Harris, J. P., Kong, C. S., Sunwoo, J. B., Divi, V., Horst, K. C., … Hara, W. Y. (2018). Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis. Oral Oncology, 85, 60–67. -
Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma
Chen, J. J., Shah, J. L., Harris, J. P., Bui, T. T., Schaberg, K., Kong, C. S., … Hara, W. Y. (2017). Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 98(4), 775–83. -
Effect of the extent of lymph node dissection on overall survival in patients treated for oral cavity squamous cell carcinoma
Shah, J. L., Kaplan, M., Divi, V., Quynh-Thu Le, & Hara, W. (2015). Effect of the extent of lymph node dissection on overall survival in patients treated for oral cavity squamous cell carcinoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.
Warner, K. A., Oklejas, A. E., Pearson, A. T., Zhang, Z., Wu, W., Divi, V., … Nor, J. E. (2018). UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line. Oral Oncology, 87, 21–28. -
Treatment of early-stage laryngeal cancer: A comparison of treatment options.
Baird, B. J., Sung, C. K., Beadle, B. M., & Divi, V. (2018). Treatment of early-stage laryngeal cancer: A comparison of treatment options. Oral Oncology, 87, 8–16. -
Depth of invasion alone as a prognostic factor in low-risk early-stage oral cavity carcinoma.
Kozak, M. M., Shah, J., Chen, M., Schaberg, K., von Eyben, R., Chen, J. J., … Hara, W. (2019). Depth of invasion alone as a prognostic factor in low-risk early-stage oral cavity carcinoma. The Laryngoscope. -
Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma.
Qian, Z. J., Chen, M. M., Divi, V., & Megwalu, U. C. (2019). Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma. Head & Neck. -
Third party assessment of resection margin status in head and neck cancer.
Ransohoff, A., Wood, D., Henry, S., Divi, V., & Colevas, A. D. (2015). Third party assessment of resection margin status in head and neck cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234.
Divi, V., Harris, J., Harari, P. M., Cooper, J. S., McHugh, J. B., Bell, D., … Holsinger, F. C. (2015). Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
The Multidisciplinary, Function-Oriented Evaluation.
Hara, W., & Divi, V. (2017). The Multidisciplinary, Function-Oriented Evaluation. International Journal of Radiation Oncology, Biology, Physics, 97(5), 891. -
End-of-Life Costs and Hospice Utilization in Patients with Head and Neck Cancer.
Chen, M. M., Rosenthal, E. L., & Divi, V. (2019). End-of-Life Costs and Hospice Utilization in Patients with Head and Neck Cancer. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599819846072. -
Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis
Chen, J. J., Harris, J. P., Kong, C. S., Sunwoo, J. B., Divi, V., Horst, K. C., … Hara, W. Y. (2018). Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis. ORAL ONCOLOGY, 85, 60–67. -
PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma
Amoils, M., Kim, J., Lee, C., Sunwoo, J. B., Colevas, A. D., Aasi, S. Z., … Divi, V. (2019). PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 160(1), 93–99. -
Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio, N., van den Berg, N. S., van Keulen, S., Martin, B. A., Fakurnejad, S., Zhou, Q., … Rosenthal, E. L. (2019). Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer. Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging. -
Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence
Gao, R. W., Teraphongphom, N. T., van den Berg, N. S., Martin, B. A., Oberhelman, N. J., Divi, V., … Rosenthal, E. L. (2018). Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence. CANCER RESEARCH, 78(17), 5144–54. -
Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy.
Hwang, V., Mendez, E., Chow, L. Q., Futran, N. D., Andersen, P., Li, R., … Rodriguez, C. P. (2019). Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy. The Laryngoscope. -
Association of surgical quality metrics and hospital-level overall survival for patients with head and neck squamous cell carcinoma.
Schoppy, D. W., Ma, Y., Rhoads, K. F., Chen, M. M., Nussenbaum, B., Orosco, R. K., … Divi, V. (2017). Association of surgical quality metrics and hospital-level overall survival for patients with head and neck squamous cell carcinoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Reducing the Time from Surgery to Adjuvant Radiation Therapy: An Institutional Quality Improvement Project
Divi, V., Chen, M. M., Hara, W., Shah, D., Narvasa, K., Smith, A. S., … Porter, J. (2018). Reducing the Time from Surgery to Adjuvant Radiation Therapy: An Institutional Quality Improvement Project. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 159(1), 158–65. -
Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer
Chen, M. M., Harris, J. P., Orosco, R. K., Sirjani, D., Hara, W., & Divi, V. (2018). Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 158(6), 1051–56. -
Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients
Saraswathula, A., Chen, M. M., Mudumbai, S. C., Whittemore, A. S., & Divi, V. (2019). Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 160(3), 380–87. -
Jaw Opening Decreases Window to the Deep Parotid Lobe
Lee, Y.-J., Megwalu, U., Melara, E., Divi, V., Fernandes, V. T., & Sirjani, D. (2018). Jaw Opening Decreases Window to the Deep Parotid Lobe. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 159(3), 439–41. -
Treatment of early-stage laryngeal cancer: A comparison of treatment options
Baird, B. J., Sung, C. K., Beadle, B. M., & Divi, V. (2018). Treatment of early-stage laryngeal cancer: A comparison of treatment options. ORAL ONCOLOGY, 87, 8–16. -
Regionalization of head and neck cancer surgery may fragment care and impact overall survival
Chen, M. M., Megwalu, U. C., Liew, J., Sirjani, D., Rosenthal, E. L., & Divi, V. (2019). Regionalization of head and neck cancer surgery may fragment care and impact overall survival. LARYNGOSCOPE, 129(6), 1413–19. -
Outcomes in Head and Neck Resections That Require Multiple-Flap Reconstructions A Systematic Review
Gao, R. W., Nuyen, B. A., Divi, V., Sirjani, D., & Rosenthal, E. L. (2018). Outcomes in Head and Neck Resections That Require Multiple-Flap Reconstructions A Systematic Review. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 144(8), 746–52. -
Corrigendum to 'Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis'. [Oral Oncol. 85 (2018) 60-67].
Chen, J. J., Harris, J. P., Kong, C. S., Sunwoo, J. B., Divi, V., Horst, K. C., … Hara, W. Y. (2019). Corrigendum to 'Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis'. [Oral Oncol. 85 (2018) 60-67]. Oral Oncology. -
Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma
Qian, Z. J., Chen, M. M., Divi, V., & Megwalu, U. C. (2019). Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 41(6), 1903–7. -
Radioactive iodine in differentiated thyroid cancer: a national database perspective.
Orosco, R., Hussain, T., Noel, J. E., Chang, D., Dosiou, C., Mittra, E., … Orloff, L. (2019). Radioactive iodine in differentiated thyroid cancer: a national database perspective. Endocrine-Related Cancer. -
Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment.
Nishio, N., van Keulen, S., van den Berg, N. S., Lu, G., LaRochelle, E. P., Davis, S. C., … Rosenthal, E. L. (2019). Probe-based fluorescence dosimetry of an antibody-dye conjugate to identify head and neck cancer as a first step to fluorescence-guided tissue preselection for pathological assessment. Head & Neck. -
End-of-Life Costs and Hospice Utilization in Patients with Head and Neck Cancer
Chen, M. M., Rosenthal, E. L., & Divi, V. (2019). End-of-Life Costs and Hospice Utilization in Patients with Head and Neck Cancer. OTOLARYNGOLOGY-HEAD AND NECK SURGERY. SAGE PUBLICATIONS LTD. -
Real-world efficacy of bone modifying agents (BMAs) in patients with breast cancer (BC) treated in an academic health system: Use of the "green button.
Karimi, Y., Gombar, S., Dean, L., Hansen, J., Callahan, A., Jung, K., … Blayney, D. W. (2019). Real-world efficacy of bone modifying agents (BMAs) in patients with breast cancer (BC) treated in an academic health system: Use of the "green button. JOURNAL OF CLINICAL ONCOLOGY, 37(15). -
Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer.
Zenga, J., Divi, V., Stadler, M., Massey, B., Campbell, B., Shukla, M., … Pipkorn, P. (2019). Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer. Oral Oncology, 98, 125–31. -
Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer.
Saraswathula, A., Chen, M. M., Colevas, A. D., & Divi, V. (2019). Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer. JAMA Otolaryngology-- Head & Neck Surgery. -
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer.
Nishio, N., van den Berg, N. S., van Keulen, S., Martin, B. A., Fakurnejad, S., Teraphongphom, N., … Rosenthal, E. L. (2019). Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer. Nature Communications, 10(1), 5044. -
Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy
Hwang, V., Mendez, E., Chow, L. Q. M., Futran, N. D., Andersen, P., Li, R., … Rodriguez, C. P. (2019). Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy. LARYNGOSCOPE, 129(12), E428–E433. -
Effect of Medical Scribes on Outpatient Oncology Visits at a Multidisciplinary Cancer Center.
Gao, R. W., Dugala, A., Maxwell, J., Falconer, P., Birkeland, A. C., Divi, V., & Rosenthal, E. L. (2019). Effect of Medical Scribes on Outpatient Oncology Visits at a Multidisciplinary Cancer Center. Journal of Oncology Practice, JOP1900307. -
The Impact of Hospital Quality on Thyroid Cancer Survival.
Megwalu, U. C., Ma, Y., Hernandez-Boussard, T., Divi, V., & Gomez, S. L. (2020). The Impact of Hospital Quality on Thyroid Cancer Survival. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599819900760. -
Tracheostomy Complications in the Emergency Department: A National Analysis of 38,271 Cases.
Kligerman, M. P., Saraswathula, A., Sethi, R. K., & Divi, V. (2020). Tracheostomy Complications in the Emergency Department: A National Analysis of 38,271 Cases. ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties, 1–8. -
Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer
Nishio, N., van den Berg, N. S., van Keulen, S., Martin, B. A., Fakurnejad, S., Zhou, Q., … Rosenthal, E. L. (2020). Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer. MOLECULAR IMAGING AND BIOLOGY, 22(1), 156–64. -
Radiographic surveillance of abdominal free fat graft in complex parotid pleomorphic adenomas: A case series.
Lee, Y.-J. J., Fischbein, N. J., Megwalu, U., Baik, F. M., Divi, V., Kaplan, M. J., & Sirjani, D. B. (2020). Radiographic surveillance of abdominal free fat graft in complex parotid pleomorphic adenomas: A case series. Heliyon, 6(5), e03894. -
Physician-Assisted Suicide for Patients with Head and Neck Cancer.
Kligerman, M. P., & Divi, V. (2020). Physician-Assisted Suicide for Patients with Head and Neck Cancer. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599820923610. -
Compensatory motion scaling for time-delayed robotic surgery.
Orosco, R. K., Lurie, B., Matsusaki, T., Funk, E. K., Divi, V., Holsinger, F. C., … Yip, M. (2020). Compensatory motion scaling for time-delayed robotic surgery. Surgical Endoscopy. -
Correction to: Compensatory motion scaling for time-delayed robotic surgery.
Orosco, R. K., Lurie, B., Matsuzaki, T., Funk, E. K., Divi, V., Holsinger, F. C., … Yip, M. (2020). Correction to: Compensatory motion scaling for time-delayed robotic surgery. Surgical Endoscopy. -
Impact of mortality reviews on supportive care utilization, end-of-life care, and inpatient mortality.
Karimi, Y., Divi, V., Srinivas, S., Smith, A. S., Hansen, J., Tokareva, I., … Blayney, D. W. (2019). Impact of mortality reviews on supportive care utilization, end-of-life care, and inpatient mortality. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY. -
Significance of Nodal Metastasis in Parotid Gland Acinar Cell Carcinoma.
Moon, P., Tusty, M., Divi, V., & Megwalu, U. C. (2020). Significance of Nodal Metastasis in Parotid Gland Acinar Cell Carcinoma. The Laryngoscope. -
Development and validation of a surgical prioritization and ranking tool and navigation aid for head and neck cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.
de Almeida, J. R., Noel, C. W., Forner, D., Zhang, H., Nichols, A. C., Cohen, M. A., … Gilbert, R. (2020). Development and validation of a surgical prioritization and ranking tool and navigation aid for head and neck cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic. Cancer. -
Abstract 2033: Reducing cancer caregiver burden: A user-centered design approach for an mHealth app
Oakley-Girvan, I., Divi, V., Palesh, O., Daniels, J., Goldman Rosas, L., O'Brien, D., … Longmire, M. R. (2020). Abstract 2033: Reducing cancer caregiver burden: A user-centered design approach for an mHealth app. CANCER RESEARCH, 80. -
Association Between Immunosuppression and Outcomes in Oral Cavity Squamous Cell Carcinoma.
Chang, J., Sunwoo, J. B., Shah, J. L., Hara, W., Hong, J., Colevas, A. D., & Divi, V. (2020). Association Between Immunosuppression and Outcomes in Oral Cavity Squamous Cell Carcinoma. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 194599820960146. -
Quality Outcome Measures in Neck Dissection
Divi, V., & Amoils, M. (2019). Quality Outcome Measures in Neck Dissection. NECK DISSECTION, 291–94. -
Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.
Xiang, M., Holsinger, F. C., Gensheimer, M. F., Divi, V., Pollom, E. L., Colevas, A. D., … Beadle, B. M. (2021). Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma. American Journal of Clinical Oncology, Publish Ahead of Print. -
End-of-Life Practice Patterns in Head and Neck Cancer.
Vukkadala, N., Fardeen, T., Ramchandran, K., & Divi, V. (2021). End-of-Life Practice Patterns in Head and Neck Cancer. The Laryngoscope. -
The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database.
Campbell, D. A., Pipkorn, P., Divi, V., Stadler, M., Massey, B., Campbell, B., … Zenga, J. (2021). The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database. American Journal of Otolaryngology, 42(5), 103012. -
UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line
Warner, K. A., Oklejas, A. E., Pearson, A. T., Zhang, Z., Wu, W., Divi, V., … Nor, J. E. (2018). UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line. ORAL ONCOLOGY, 87, 21–28. -
Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure Reply
Schoppy, D. W., & Divi, V. (2018). Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure Reply. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 144(6), 542. -
Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment.
Moreno-Nieves, U. Y., Tay, J. K., Saumyaa, S., Horowitz, N. B., Shin, J. H., Mohammad, I. A., … Sunwoo, J. B. (2021). Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment. Proceedings of the National Academy of Sciences of the United States of America, 118(28). -
Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study
Oakley-Girvan, I., Davis, S. W., Kurian, A. W., Rosas, L. G., Daniels, J., Palesh, O. G., … Divi, V. (2021). Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Formative Research, 5(8). -
Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study.
Oakley-Girvan, I., Davis, S. W., Kurian, A., Rosas, L. G., Daniels, J., Palesh, O. G., … Divi, V. (2021). Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Formative Research, 5(8), e22608. -
Timing of postoperative oral feeding after head and neck mucosal free flap reconstruction
Stramiello, J., Nuyen, B., Saraswathula, A., Blumenfeld, L., Divi, V., Rosenthal, E., … Starmer, H. M. (2021). Timing of postoperative oral feeding after head and neck mucosal free flap reconstruction. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY. -
Practice patterns of virtual surgical planning: Survey of the reconstructive section of the American Head and Neck Society.
Miles, B. A., McMullen, C. P., Sweeny, L., Zenga, J., Li, R., Divi, V., … Richmon, J. D. (2021). Practice patterns of virtual surgical planning: Survey of the reconstructive section of the American Head and Neck Society. American Journal of Otolaryngology, 43(1), 103225. -
Timing of postoperative oral feeding after head and neck mucosal free flap reconstruction.
Stramiello, J., Nuyen, B., Saraswathula, A., Blumenfeld, L., Divi, V., Rosenthal, E., … Starmer, H. M. (2021). Timing of postoperative oral feeding after head and neck mucosal free flap reconstruction. Laryngoscope Investigative Otolaryngology, 6(5), 1031–1036. -
Preventing 30-day readmissions for patients with cancer: A root-cause analysis
Shah, M. P., Tan, I., Garrigues, S. K., Hansen, J., Blayney, D. W., & Divi, V. (2021). Preventing 30-day readmissions for patients with cancer: A root-cause analysis. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Risk factors for ED visits and admissions during outpatient chemotherapy in head and neck cancer
Shukla, N., Saraswathula, A., Khan, S. A., & Divi, V. (2021). Risk factors for ED visits and admissions during outpatient chemotherapy in head and neck cancer. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Clinician Attitudes and Beliefs About Deintensifying Head and Neck Cancer Surveillance.
Chen, M. M., Mott, N. M., Miller, J., Kazemi, R., Stover, M., Graboyes, E. M., … Dossett, L. A. (2021). Clinician Attitudes and Beliefs About Deintensifying Head and Neck Cancer Surveillance. JAMA Otolaryngology-- Head & Neck Surgery. -
Cutaneous branch of the nerve to the mylohyoid muscle: potential cause of postoperative sensory alteration in the submental area.
Iwanaga, J., Ibaragi, S., Okui, T., Divi, V., Ohyama, Y., Watanabe, K., … Tubbs, R. S. (2022). Cutaneous branch of the nerve to the mylohyoid muscle: potential cause of postoperative sensory alteration in the submental area. Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft, 151934. -
Head and Neck Oncology Is on the National Quality Sidelines No Longer-Put Me in, Coach.
Graboyes, E. M., Divi, V., & Moore, B. A. (2022). Head and Neck Oncology Is on the National Quality Sidelines No Longer-Put Me in, Coach. JAMA Otolaryngology-- Head & Neck Surgery. -
Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
Kligerman, M. P., Moon, P. K., Tusty, M., Cloutier, J. M., Ma, Y., Holsinger, C. F., & Divi, V. (2022). Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma. The Annals of Otology, Rhinology, and Laryngology, 34894221111223. -
Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
Miller, J. A., Moradi, F., Sundaram, V., Liang, R., Zhang, C., Nguyen, N. K., … Gensheimer, M. F. (2022). Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma. Head & Neck. -
Practice patterns in transoral robotic surgery: results of an American head and neck society survey.
Holcomb, A. J., Kammer, R., Holman, A., Goldsmith, T., Divi, V., Starmer, H. M., … Richmon, J. D. (2022). Practice patterns in transoral robotic surgery: results of an American head and neck society survey. Journal of Robotic Surgery. -
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
Gross, N. D., Miller, D. M., Khushalani, N. I., Divi, V., Ruiz, E. S., Lipson, E. J., … Rischin, D. (2022). Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. The New England Journal of Medicine. -
Minimally Invasive Surgery in the United States, 2022: Understanding Its Value Using New Datasets.
Mattingly, A. S., Chen, M. M., Divi, V., Holsinger, F. C., & Saraswathula, A. (2022). Minimally Invasive Surgery in the United States, 2022: Understanding Its Value Using New Datasets. The Journal of Surgical Research, 281, 33–36. -
Reducing inpatient mortality in patients with cancer through multidisciplinary review and targeted interventions.
Shah, M. P., Garrigues, S. K., Khaki, A. R., Hansen, J., Divi, V., & Blayney, D. W. (2022). Reducing inpatient mortality in patients with cancer through multidisciplinary review and targeted interventions. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Head-to-Head Comparison of ChatGPT Versus Google Search for Medical Knowledge Acquisition.
Ayoub, N. F., Lee, Y.-J., Grimm, D., & Divi, V. (2023). Head-to-Head Comparison of ChatGPT Versus Google Search for Medical Knowledge Acquisition. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. -
Oral cavity cancer in young, non-smoking, and non-drinking patients: a contemporary review.
Tran, Q., Maddineni, S., Arnaud, E. H., Divi, V., Megwalu, U., Topf, M. C., & Sunwoo, J. B. (2023). Oral cavity cancer in young, non-smoking, and non-drinking patients: a contemporary review. Critical Reviews in Oncology/Hematology, 104112. -
Toll-like Receptor Agonists Are Unlikely to Provide Benefits in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Maddineni, S., Chen, M., Baik, F., Divi, V., Sunwoo, J. B., & Finegersh, A. (2023). Toll-like Receptor Agonists Are Unlikely to Provide Benefits in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 15(17). -
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Gross, N. D., Miller, D. M., Khushalani, N. I., Divi, V., Ruiz, E. S., Lipson, E. J., … Rischin, D. (2023). Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study. The Lancet. Oncology.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma »
- TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources »
- Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma »
- Panitumumab IRDye800 Optical Imaging Study »
- Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer »
- Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures »
- Study Evaluating Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck Squamous Cell Carcinoma »
Practice Locations
Head and Neck Cancer Program at 900 Blake Wilbur Palo Alto, CA
Palo Alto, CA
Head and Neck Cancer Program at 900 Blake Wilbur
900 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Pituitary Center Palo Alto, CA
Palo Alto, CA
Pituitary Center
213 Quarry Road
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Head and Neck Cancer Program in Pleasanton Pleasanton, CA
Pleasanton, CA
Head and Neck Cancer Program in Pleasanton
5725 W. Las Positas Blvd, Suite 100
Pleasanton , CA 94588
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(166 reviews)
Dr Divi and his team are so exceptional. Everyone is so talented, professional, friendly and patient centered. Wonderful care at every corner.
Very kind and informative
Excellent doctor and staff
I was looking for a 2nd opinion and options...I found both...well worth my time.
Professional, personalized examination. Comforted by the sense one is in the hands of top drawer medical staff.
Dr. Divi was very professional and gentle when I visited his office. I was comfortable and positive that he will take good care of me on my surgery day. His team were great. Thank you Dr. Divi and to all your team. Greatly appreciate all your service and assistance.
Lily Lam and Dr Divi took my situation very seriously, provided clear and thoughtful explanations, and answered all of my questions
He’s the greatest surgeon in the world!
Everybody was super nice and helpful. Was a good experience
THOROUGH AND KIND would be my adjectives for Dr Divi He gave me new and disturbing information and was
Great
Very friendley people, i even got a hug from the lady at the information desk.
Very friendly people. Everything was completely explained
Dr. Divi is THE BEST that Stanford ever had. He has an awesome personality and very accommodating. He is very compassionate and knowledgeable and took care of me. Lily, his NP, is also awesome. I love them both!
Everyone was very warm and welcoming
Dr. Divi saved my life. I am internal grateful to have been referred to such a talented surgeon and a caring one.
Excellent Doctor
As always very polite, courteous and professional Dr and staff
Professional..
Dr Divi does wonderful work, no more pain, Thank you Dr Divi
What can I say about the physician that alongside Dr. Benjamin Erickson saved my life? Amazing as always. His team would have to be up to Dr. Divi’s standards. As always they are above and beyond consistently for the last 3 years since I have been a patient. Thank you!
Excellent doctor and staff
Dr Divi is the best!
Exceptional care.
a very fine dOCTOR
everyone we encountered was extremely friendly and professional
I am very impressed by Dr Divi
Great Dr. Great staff. Great options and explanations!! Thank you Dr Divii
Dr.Divi & his staff were excellent I was very happy many thanks
Dr. Divi totally took his time and answered my questions very honestly and I really appreciate it not being rushed and being allowed to have my family members there
The care that I receive from everyone at Stanford has been great
Excellent service from the entire staff everyone seem to be very caring and patient I was very impressed
Very through exam and consideration.
The staff is very concerned about my conditions. I know I am in good professional hands
Wonderful, caring manner, explained the options clearly and he is very easy on the eyes.
Was very impressed with Dr Divi and his team
Very personable, informative, answered my questions
Patient friendly, great bedside manner, knowledgeable, caring, very skilled surgeon. I even drove from Tennessee annually for my check up as I trusted he and his office associates.
A wonderful Hospital.
Very amazed at the caring staff felt comfortable during my visit.
Great visit
The doctor and the team were very good at explaining what would probably happen, and they answered my questions well.
Dr divi is amazing
It is good for me .
very nice and professional, thanks a lot
All the Dr. and nurses are very nice feel the patient fearless thank you.
Dr Divi and his team are 11 on a scale of 10
Very caring professionals. Made a difficult time as easy as possible. Thank you
Everyone from the Imaging Center on Sherman street to Dr Divi and his team has been incredibly helpful. Our family deeply appreciate your time and help during this difficult time.
Always giving all the credit to Stanford for my recovery.
Dr. Divi was really wonderful. My dad loved coming in. He thought everyone was so nice.
Dr Divi is very knowledgeable, caring, takes time to explain his plan of care.
Though Dr. Divi's speciality is Head & Neck, is anyone has an issue such as mine, I would readily refer them to Dr. Divi.
Very helpful, everyone from his office has been extremely kind and helpful.
Very good and personable care from Lily Lam and Dr Divi
Dr. Divi was genuinely concerned and he made me feel reassured.
very highly recommend
Very good in all area's.
(Outstanding.)
Good.
Dr. Vasu Divi and Lily Lam are the best.
I'm very pleased w/my provider. She is excellent. I have complete trust in her.
The doctor was very kind and explained very well the situation.
I am so happy with my care providers thank you so much for care for me.
Lily & Dr. Divi are wonderful - !
Excellent doctor.
Dr. Divi is fantastic! He is caring, informed, conscientious and an amazing surgeon.
Excellent care!!
Dr. Divi is excellent!
They have treated me very well.
Not a good experience.
Dr. Divi is an exceptionally brilliant, caring, patient, thorough doctor with amazing communication capabilities. He saved my life and I will forever be grateful to him. Lily Lam, his NP, is remarkably kind, informative and supportive. I can't express my respect for them enough.
Dr. spent as much time as I needed. Dr. Divi has saved my life.
Both Dr. Divi and Dr. Pepper explained procedure, friendly courteous answered all questions.
Treated with much courtesy.
It was my first time, and I felt comfortable with their professionalism and surely I recommend in the future after my surgery and recovery.
Both Dr. Divi and Lily Lam were very good.
Wonderful.
The staff at Stanford is wonderful!
All good. Dr. Divi is "tops."
Willing to provide more information (explanation) than other providers I visited in other healthcare.
Always WELL attended!
We love Dr. Divi!
Dr. Divi is the BEST!
At this point in treatment Dr. Divi has extended my life by years.
Excellent.
Dr. Divi is the best Doctor I have ever met. He has the most excellent care and doesn't make you feel rushed. He is very caring and compassionate. Dr. Divi and Lily are the best and truly a "gem".
The best.
Dr. Divi and his assistants are always kind, helpful, very concerned about my needs. Excellent care and attention to details.
I love all you people you are wonderful to me.
Good, friendliness, very helpful.
Very good experience.
All the personnel treated me very well thanks.
Love my drs.
I would refer him as the best in his field.
Everyone was really great and kind to me. My age didn't matter to them. Wonderful place to be.
All very good.
Excellent doctor.
Dr. Divi and Lily Lam were both extremely helpful, supportive and informative! Dr. Divi is a REMARKABLE surgeon, and 1 credit him with saving my life.
Everyone at Stanford is awesome!
Lily, Andrew, Dr. Divi were exceptional!
He didn't provide good information on how to care for my wound after surgery. When I called for clarification, it took two days of phone calls to get a simple answer.
Very very good experience.
Excellent care; quick referrals to tests & professionals I needed.
So good.
Excellent & proactive physician.
Wonderful.
I'm very satisfied with Dr. Divi.
Excellent experience - surgery was compressed & accomplished with in ten days from introduction to major surgery on my scalp!
Excellent experience. Impressed with physicians knowledge and ability to communicate complicated situation in compassionate steady way. Felt in excellent hands. Relieved to be in this physician & his nurses care. Felt confident of their capabilities.
Good.
All involved in my care demonstrated exceptional care and were easy to talk with. They provided superior care.
Nothing but good experience.
My visits w/Dr. Divi and Lily are always pleasant. They both explain everything to where I can understand. I have all the confidence in the world with Dr. Divi and Lily. I am in debt to both of them for all they have done for me.
Excellent experience as always! Thank you!
Dr. Divi always takes the time to listen and answer all my questions he cares about me as a person and is empathetic.
I put myself in good hands with Dr. Divi and Lily. I totally have faith on them and would recommend them to everyone.
Really outstanding experience.
I'm very lucky to have Dr. Divias my cancer doctor. He performed a miracle surgery on my tongue.
All information given is to where I understand Dr. Divi and Lily are very courteous. Professional yet friendly - he and Lily take time to answer my concerns. They treat me with respect and I would recommend them to ALL my family & friends.
Always great.
Dr. Divi is very professional & confident. He knows exactly what he should do & when might happen later. I am very comfortable before & after the surgery. #8. Can be longer, but I understand that Dr. Divi has many patients. #9, 10. Very.
Dr. Divi came into the clinic to see me on his non-clinic day.
I had more than fair amount of courtesy, I am greatly appreciative.
Very happy with outcome, treatment while under care - no issues at all.
Dr. Divi is amazing. Lily was also great - She is a fantastic "right hand" to Dr. Divi -
I like seeing Dr. Divi.
If Dr. Divi didn't do my surgery I would probably be dead right now. After a painful death. He did a miracle surgery with a skill & talent that saved my life.
Very good.
Dr. Divi is the best.
Overall, I was very happy and more than satisfied w/ Dr. Divi AND his assistants.
Phenomenal.
All of my experiences with Dr. Divi have been very good. He has always been friendly, courteous and attentive to my concerns.
This was just a consultation - the procedure has yet to be scheduled! Yikes!
Family member asked questions & was ignored!!
So far, so good.
Very professional and honest. Takes time and explains he gives options and advice. I would recommend him 100%
Dr. Divi is always very clear and shows great care when speaking with me. The NP's have also been extremely attentive and show good concern.
Very good experience with the doctor very kind & their personnel too.
Dr. Divi takes the extra time needed to answer all my questions. He is skilled, focused, thorough, and concerned for me as a person.
I feel better when greeted with a smile - they usually do smile.
Dr. Divi is very knowledgeable & professional.
They made each visit enjoyable as possible.
Very good.
V. good.
The dr. hasn't given up yet on me. He's trying to keep checking on my cancer problems.
Dr. Divi is simply - the BEST!
GOOD - they taught us how to take care of the patient after her discharge, we had lots of fun!
No bad experience - Everything was perfect! Dr. Divi is one of the best MD!!!
Very good feelings about Dr. Divi.
Dr. Divi Vasu was incredibly good on all sectors. He made the exact (and reassuring) diagnosis and instructed Lily Lau, RN for follow up.
V. good.
Excellent care.
Too much delay.
Good.
Good.
They did a terrific job.
Again surpassing my expectations!!!
I just don't know doctor well enough but he seemed to be very busy.
Dr. Divi is thorough, focused, skilled and caring.
Could not have been better. A true professional!
Only good experiences.
Dr. Divi is an excellent doctor!!!
I feel Dr. Divi stood between myself and this disaster called cancer. Dr. Divi is my knight in shining armor!
Dr. Divi is a wonderful doctor even if he does look like a kid!!
HE SAVED MY LIFE.
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records